{
    "2021-10-18": [
        [
            {
                "time": "2021-ESMO",
                "original_text": "医药健康：ESMO 2021落幕 国产创新药逐渐开花结果",
                "features": {
                    "keywords": [
                        "ESMO",
                        "国产创新药",
                        "开花结果"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "200个药首家过评：恒瑞、齐鲁、正大天晴",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "齐鲁",
                        "正大天晴",
                        "首家过评"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-疫苗加强针",
                "original_text": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
                "features": {
                    "keywords": [
                        "疫苗加强针",
                        "三季报",
                        "业绩预期差"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-北向资金",
                "original_text": "北向资金净卖出额创近2个月新高，贵州茅台遭大幅抛售逾14亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净卖出",
                        "贵州茅台"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-恒瑞临床试验",
                "original_text": "恒瑞医药：注射用SHR-A2009获批开展晚期或转移性实体瘤临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-A2009",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-两融余额",
                "original_text": "A股融资融券日报：两融余额减少36.07亿元（10月15日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-创新药国谈",
                "original_text": "医药生物行业：创新药国谈价格前瞻分析",
                "features": {
                    "keywords": [
                        "创新药",
                        "国谈",
                        "价格前瞻"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}